Please login to the form below

Not currently logged in
Email:
Password:

Teva acquires Taiyo for almost $1bn

Teva Pharmaceutical has completed the full acquisition of Japanese generics manufacturer Taiyo in a cash deal worth $934m

Teva Pharmaceutical has completed the full acquisition of Japanese generics manufacturer Taiyo in a cash deal worth $934m.

The agreement follows Israel-based Teva's agreement in May 2011 to acquire 57 per cent of the share held in Taiyo for $460m in cash.

Teva is already the largest generics company in the world, and will add a portfolio of over 550 products and a strong Japanese presence to its business.

Taiyo currently has annual sales of around $530m in a market where generic penetration is relatively low but is being actively encouraged by the Japanese government.

According the Teva, the company expects to reach $1bn in sales in Japan, ahead of its original 2015 target.

Teva president and CEO, Shlomo Yanai, described the acquisition as an "important milestone" for the company.

He continued: "The acquisition of Taiyo, along with Teva's existing Japanese business, assures that Teva will deliver on our strategic objective of becoming a leading player in Japan."

14th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics